Shenzhen - Delayed Quote • CNY
Maccura Biotechnology Co.Ltd (300463.SZ)
At close: April 26 at 3:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,835,736.30
2,895,769.51
3,608,411.90
3,980,647.18
3,703,877.01
Cost of Revenue
1,255,639.70
1,295,317.80
1,651,770.74
1,673,940.19
1,736,392.02
Gross Profit
1,580,096.60
1,600,451.71
1,956,641.16
2,306,706.99
1,967,484.99
Operating Expense
1,138,919.28
1,148,936.78
1,061,714.12
1,003,841.29
868,311.52
Operating Income
441,177.32
451,514.94
894,927.04
1,302,865.71
1,099,173.47
Net Non Operating Interest Income Expense
-22,026.16
-24,420.44
-23,623.47
-55,681.46
-65,477.85
Pretax Income
306,310.68
305,368.97
789,083.52
1,187,127.55
969,765.90
Tax Provision
-4,785.80
689.90
87,378.34
184,879.44
148,411.43
Net Income Common Stockholders
316,187.05
312,618.56
708,180.36
956,604.40
793,917.99
Basic EPS
0.52
0.51
1.17
1.73
1.43
Diluted EPS
0.52
0.51
1.17
1.72
1.42
Basic Average Shares
605,452.55
608,680.99
603,940.27
552,694.94
553,986.45
Diluted Average Shares
609,268.73
612,497.17
607,827.96
556,812.81
557,409.24
Total Operating Income as Reported
327,280.97
331,144.76
817,394.59
1,214,066.13
989,690.30
Total Expenses
2,394,558.98
2,444,254.58
2,713,484.86
2,677,781.48
2,604,703.54
Net Income from Continuing & Discontinued Operation
316,187.05
312,618.56
708,180.36
956,604.40
793,917.99
Normalized Income
375,968.00
418,031.93
760,262.23
983,051.05
828,219.77
Interest Income
10,244.49
10,030.79
12,005.81
5,004.90
4,330.47
Interest Expense
33,387.15
33,532.98
35,055.77
59,273.86
68,185.42
Net Interest Income
-22,026.16
-24,420.44
-23,623.47
-55,681.46
-65,477.85
EBIT
339,697.83
338,901.96
824,139.29
1,246,401.41
1,037,951.32
EBITDA
339,697.83
651,984.59
1,094,338.06
1,482,601.40
1,243,169.85
Reconciled Cost of Revenue
1,255,639.70
1,295,317.80
1,651,770.74
1,673,940.19
1,736,392.02
Reconciled Depreciation
--
313,082.63
270,198.77
236,199.99
205,218.53
Net Income from Continuing Operation Net Minority Interest
316,187.05
312,618.56
708,180.36
956,604.40
793,917.99
Total Unusual Items Excluding Goodwill
-99,634.92
-105,652.07
-58,567.25
-31,325.12
-40,499.80
Total Unusual Items
-99,634.92
-105,652.07
-58,567.25
-31,325.12
-40,499.80
Normalized EBITDA
439,332.74
757,636.65
1,152,905.31
1,513,926.53
1,283,669.65
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-39,853.97
-238.69
-6,485.38
-4,878.47
-6,198.03
12/31/2020 - 5/28/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade